微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 2.34% | -27.33% | 58.11% | 98/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.48% | -36.48% | 4.23% | 95/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.42% | -2.07% | -50% | 76/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 2.84% | 32.71% | -11.8% | 82/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 3.22% | 3.54% | 38.2% | 90/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.33% | 0.43% | 60.69% | 79/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.45% | 9.02% | -32.24% | 74/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 2.14% | -14.06% | -31.19% | 96/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 3.11% | -7.44% | 34.05% | 83/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.32% | -21.09% | 74.44% | 80/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.33% | 9.02% | -46.59% | 77/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 2.49% | -15.88% | -25.89% | 97/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 3.36% | 25.84% | 14.29% | 93/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.94% | 64.25% | 140.98% | 81/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.22% | 227.08% | -58.78% | 90/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 2.96% | 100% | 10.86% | 99/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 2.67% | -67.87% | 49.16% | 86/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 1.79% | -36.07% | 286.46% | 92/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | -0.96% | -112.97% | -164.86% | 94/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 1.48% | -68.1% | -82.19% | 114/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 8.31% | 82.24% | 196.79% | 44/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.8% | -18.6% | -62.16% | 77/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 7.4% | 311.11% | 59.48% | 7/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 4.64% | -2.11% | 1.75% | 90/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 4.56% | -17.39% | 32.56% | 73/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 3.44% | -9.47% | 91.11% | 65/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.8% | 7.14% | -62.03% | 61/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 4.74% | -33.33% | -14.13% | 87/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 5.52% | -10.53% | 45.26% | 62/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 3.8% | -9.52% | 126.19% | 64/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.68% | -13.4% | -76.37% | 49/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 7.11% | -2.6% | 15.24% | 71/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 6.17% | -9.53% | 46.9% | 45/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 4.2% | 0.24% | 116.49% | 45/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 1.94% | -20.49% | -73.42% | 40/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 7.3% | -3.44% | 7.04% | 61/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 6.82% | -4.88% | 62.77% | 38/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 4.19% | -15.18% | 71.72% | 44/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 2.44% | 32.61% | -67.72% | 35/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |